CIK: 0001780067
Total reported value
$631.0M
Reporting period: 2020-12-31 · Number of holdings: 7
Atlas Venture Associates IX, LLC disclosed 7 holdings in its latest 13F filing for the period ending 2020-12-31, with total reported value of $631.0M and a quarterly turnover rate of 0.0%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "A"
Atlas Venture Associates IX, LLC's disclosed holdings carry a Herfindahl concentration index of 0.568 — mathematically equivalent to about 2 equally-sized positions, well below its 7 actual disclosed holdings. That gap points to a strategy built around a small core of high-conviction bets rather than broad diversification.
Position sizes vary widely across the portfolio (a coefficient of variation of 1.86), with a handful of outsized bets alongside many smaller positions.
No strong tilt toward either adding to existing winners or initiating outsized new positions was observed in the latest reported quarter.
Sector classification currently covers about 1% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
No holding changes this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Skillz INC | Stock-Other | 73.80% | — | — | — |
| 2 | NTLA | Intellia Therapeutics INC | Stock-Other | 13.93% | — | — | — |
| 3 | SURFUSD | Surface Oncology INC | Stock-Other | 4.31% | — | — | — |
| 4 | SPRO | Spero Therapeutics INC | Stock-Other | 4.23% | — | — | — |
| 5 | COGT | Cogent Biosciences INC | Stock-Other | 1.63% | — | — | — |
| 6 | SNAP | Snap INC - A | Stock-Comm Services | 1.19% | — | — | — |
| 7 | ✓ | Synlogic INC | Stock-Other | 0.91% | — | — | — |
Not enough priced holdings yet to compute performance
Not enough data yet to compute personality scores
Not enough sector-mapped data yet
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2020-12-31 | 2021-02-11 | Amendment | View on EDGAR |
| 2020-12-31 | 2021-02-01 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001676603
Total reported value
$631.2M
230 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001600285
Total reported value
$631.2M
10 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001569141
Total reported value
$630.7M
88 stks
2021-12-31
Stale — no recent filing
AUM within 0.1% of this institution
Institutions with overlapping top holdings
CIK 0001671207
Total reported value
$11.8M
6 stks
2023-09-30
Stale — no recent filing
2 of the top 5 holdings overlap
CIK 0000872589
Total reported value
$47.9M
2 stks
2026-03-31
1 of the top 5 holdings overlap, including Intellia Therapeutics INC
CIK 0001009258
Total reported value
$8.5B
82 stks
2026-03-31
1 of the top 5 holdings overlap, including Cogent Biosciences INC